Criteria for hepatitis B virus screening and validation of blood components in Italy: The position of the SIMTI HBV working group

Blood Transfusion

Volumn 9, Issue 4, 2011, Pages 455-461

  Velati, Claudio ^a   Fomiatti, Laura ^a   Baruffi, Lorella ^a   Piccinini, Vanessa ^b   Prati, Daniele ^c   Reina, Anna ^d   Lobbiani, Andrea ^e   Zanetti, Alessandro ^f   Romanò, Luisa ^f  

^a Transfusion Medicine and Haematology Department   (Italy)

^b National Blood Centre   (Italy)

^c A MANZONI HOSPITAL   (Italy)

^d San Michele Hospital   (Italy)

^e RHO HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Anti HBc; Blood donor HBV screening; HBV; HBV DNA

Indexed keywords

VIRUS DNA;

BLOOD DONOR; BLOOD TRANSFUSION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; ITALY; REVIEW; SCREENING TEST; TRANSFUSION; VASCULARIZATION;

BLOOD DONORS; DATA COLLECTION; DONOR SELECTION; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; ITALY; SOCIETIES, MEDICAL;

EID: 80054906076     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2011.0014-11     Document Type: Review

References (57)

1. Leiss W, Tyshenko M, Krewski D. Men having sex with men donor deferral risk assessment: an analysis using risk management principles. Transf Med Rev 2008; 22: 35-57.
2. Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus. Nucleic acid testing versus immunoassay methods. Mol Diag Ther 2006; 10: 77-91.
3. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-7.
4. Velati C, Fomiatti L, Baruffi L, et al. Screening delle donazioni di sangue con tecniche NAT in Italia: aggiornamento 2009. Available at http://www.simti. it/progetto.aspx?id=4&area=1. Last accessed on 12/1/2011.
5. Pisani G, Cristiano K, Marino F, et al. External quality assessment programmes for detection of HCV RNA, HIV RNA and HBV DNA in plasma: improved proficiency of the participants observed over a 2-year period. Vox Sang 2010; 99: 319-24.
6. Velati C, Fomiatti L, Reina A. et al. Malattie trasmissibili con la trasfusione: algoritmi diagnostici e fattori di rischio. Blood Transfus 2009; 7(Suppl 2): RE03.
7. World Health Organization. Hepatitis B. Fact sheet N. 204 (Revised August 2008). Available at: http://www. who.int/mediacentre/factsheets/fs204/en/index. html. Last accessed on 20/12/2010.
8. Lok AS, McMahon J. Chronic hepatitis B. Hepatology 2001; 34: 1225-41.
9. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 summary of a workshop. Gastroenterology 2001; 120: 1828-53.
10. Zanetti AR, Mariano A, Romanò L, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366: 1379-84.
11. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 18: 6266-73.
12. Mele A, Tosti ME, Mariano A, et al. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 2008; 46: 868-75.
13. Dal Molin G, Poli A, Crocè LS, et al. Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North- Eastern Italy. J Med Virol 2006; 78: 734-40.
14. Piccinini V, Pupella S, Catalano L, Grazzini G. Sorveglianza epidemiologica dei donatori di sangue e di emocomponenti, anno 2007. Notiziario dell'Istituto Superiore di Sanità 2009; 10: 15-9.
15. Velati C, Romanò L, Fomiatti L, et al. for the Italian Group for the Study of Transfusion Transmissible Diseases. HBV DNA detection in HBsAg neg/anti-core positive Italian first time blood donors. Vox Sang 2006; 91(suppl 3): 66.
16. Kleinman SH, Busch MP. HBV: amplified and back in the blood safety spotlight. Transfusion 2001; 41: 1081-5.
17. Kleinman SH, Kuhns MC, Todd DS, et al. Frequency of HBV-DNA detection in US blood donors testing positive for the presence of anti-HBc: implication for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704.
18. Kleinman SH, Strong DM, Tegtmeier GG, et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005; 45: 1247-57.
19. Busch MP. Should HBV DNA NAT replace HBsAg and/ or anti-HBc screening of blood donors? Transfus Clin Biol 2004; 11: 26-32.
20. O'Brien SF, Fearon MA, Yi QL, et al. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion 2007; 47: 1809-15.
21. Sato S, Ohhashi W, Ihara H, et al. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001; 41: 1107-13.
22. Roth WK, Weber M, Petersen D, et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002; 42: 869-75.
23. Hourfar MK, Walch A, Geusendam G, et al. Sensitivity and specificity of anti-HBc screening assays - which assay is best for blood donor screening? Int J Lab Hem 2009; 31: 649-56.
24. Hennig H, Puchta I, Luhm J, et al. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002; 100: 2637-41.
25. Manzini P, Girotto M, Borsotti R, et al. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 2007; 92: 1664-70.
26. Antar W, El-Shokry MH, Abd El Hamid WA, Helmy MF. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Transf Med 2010; 20: 409-13.
27. Yotsuyanagi H, Yasuda K, Moriya K, et al. Frequent presence of HBV in the sera of HBsAg-negative, anti- HBc-positive blood donors. Transfusion 2001; 41: 1093-9.
28. World Health Organization 2010. Screening donated blood for transfusion-transmissible infections: Recommendations. Available at www.who.int/entity/ bloodsafety/en/. Last accessed on 10/1/2011.
29. Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009; 51: 798-809.
30. Stramer SL. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Transfusion 2005; 45: 1242-6.
31. Schmidt M, Nübling CM, Scheiblauer H. Anti-HBc screening of blood donors: a comparison of nine anti- HBc tests. Vox Sang 2006; 91: 237-43.
32. Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hep 2007; 14 (Suppl. 1): 16-21.
33. Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen. Transfusion. 2011 Jan 28. DOI 10.1111/j.1537-2995.2010.03031.x. [Epub ahead of print].
34. Katz L, Strong DM, Tegtmeier G, et al. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Transfusion 2008; 48: 2315-22.
35. Yugi H, Mizui M, Tanaka J, Yoshizawa H. Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nuclei acid amplification testing - Japanese experience. J Clin Virol 2006; 36 (Suppl 1): S56-S64.
36. Vermeulen M, Lelie N, Sykes W, et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009; 49: 1115-25.
37. Brojer E, Grabarczyk P, Liszewski G, et al. Characterization of HBV DNA+/HBsAg-blood donors in Poland identified by triplex NAT. Hepatology 2006; 44: 1666-74.
38. Velati C, Romanò L, Fomiatti L, et al. for the SIMTI Research Group. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008; 48: 2205-13.
39. Margaritis AR, Brown SM, Seed CR, et al. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007; 47: 1783-93.
40. Nantachit N, Thaikruea L, Thongsawat S, et al. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 2007; 47: 1803-8.
41. Li L, Chen PJ, Chen MH, et al. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008; 48: 1198-206.
42. Bremer CM, Saniewsk M, Wend UC, et al. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009; 49: 1621-9.
43. Gerlich WH, Wagner FF, Chudy M, et al. HBsAg nonreactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007; 79: S32-S36.
44. Stramer SL, Wend U, Candotti D, et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 2011; 364: 236-47.
45. Hourfar MK, Jork C, Schottstedt V, et al. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008; 48: 1558-66.
46. Biswas R, Tabor E, Hsia CC, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003; 43: 788-98.
47. Hoofnagle JH, See: LD, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen N Engl J Med 1978; 298: 1379-83.
48. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995; 35: 5-12.
49. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV trasmission by transfusion. Br J Haematol 1999; 107: 186-95.
50. Wang JT, Lee CZ, Chen PJ, et al. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002; 42: 1592-7.
51. Inaba S, Ito A, Miyata Y, et al. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion 2006; 46: 2028-9.
52. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, et al. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008; 48: 1022-5.
53. Crookes RL, Vermeulen M, Kramvis A, et al. Hepatitis B window period transmission by blood screened by individual donation nucleic acid testing: a case report. Vox Sang 2010; 99 (Suppl.1): 294.
54. Bouike Y, Imoto S, Mabuchi O, et al. Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan. Transf Med 2011; 21: 107-15.
55. Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-89.
56. Satake M, Taira R, Yugi H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47: 1197-205.
57. Allain J-P, Reesink HW, Lucey C. A European perspective on the management of donors and units testing positive for hepatitis B virus DNA. Transfusion 2006; 46: 1256-8.